The record
Written from the 1 report below. Nothing here is unsourced.
- A new report from the Kerala Antimicrobial Resistance Surveillance Network has found high levels of drug-resistant bacteria in Kerala hospitals and in the wider community, meaning common infections in the state are becoming harder to treat with standard antibiotics.
- It matters for anyone treated in Kerala's health system: when first-line antibiotics fail, routine procedures, wounds and minor infections can turn serious, and fallback drugs tend to be costlier and harsher on patients.
- Both member reports, from The Hindu's national and Kerala editions, present the findings as straight health reporting, with no competing political or industry framing visible in the coverage available.
- Notably, the specific figures are not detailed here — which bacteria, which drugs, and how widespread each resistance pattern is remain unknown from these summaries.
- The state government's response is the next thing to watch, along with any new prescribing rules.
What to watch next
- Kerala health department's response and any antibiotic stewardship measures
- Follow-up surveillance data on which bacteria and drugs are affected
- Hospital infection-control changes or revised prescribing guidelines
- Whether national health bodies cite Kerala findings in AMR policy
Who said what1
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Anonymous senior public health expert
1 quote · 1 outlet
“Colistin is a last-resort antibiotic and in the State, its overall resistance profile is 0.1% now. But over the last seven years, we find that Colistin resistance is also emerging and it is a cause for concern”
In the article
…report shows that Colistin, an older and more toxic antibiotic that is usually reserved for treating severe infections caused by highly-resistant Gram-negative bacteria, remains largely effective in Kerala, as of now. “ Colistin is a last-resort antibiotic and in the State, its overall resistance profile is 0.1% now. But over the last seven years, we find that Colistin resistance is also emerging and it is a cause for concern ,” a senior public health expert said. Comparing data from 2018 through 2025, the report finds that ESBL production and carbapenem resistance have broadly held steady at high levels over recent years, after both had…
Why it matters5
Who is affected first and what likely follows, with a direction and a horizon. Extracted from the reports, never invented.
- Hospital patients in Kerala treatment resistant infection risk· immediate
- Kerala general community harder to treat common infections· longer
- Kerala hospitals infection control burden· days
- Kerala health authorities antibiotic stewardship pressure· weeks
- Antibiotic treatment effectiveness in Kerala rising treatment cost and toxicity· longer
Coverage1
All filed from IndiaSingle origin
Named India · Kerala · Department of Microbiology at Government Medical College, Thiruvananthapuram · Kerala Antimicrobial Resistance Surveillance Network · National Centre for Disease Control · World Health Organization
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.